The FDA Just Recalled Montelukast Pills for a Dangerous Labeling Mistake

One form of montelukast, a medication commonly prescribed to treat asthma symptoms, has been voluntarily recalled for a potentially dangerous labeling mix-up, according to a statement from the Food and Drug Administration (FDA). Specifically, the recall affects 30-pill bottles of 10 milligram montelukast tablets (a generic version of Singulair) manufactured by Camber Pharmaceuticals, the statement […]